Showing results (751-760 of 1,892) with videos related to

Sort By:
Pageof 190
Immunotherapy|September 8, 2017
Two is better than one: advances in pathogen-boosted immunotherapy and adoptive T-cell therapyGang Xin, David M Schauder, Ryan Zander, et al.
Immunotherapy|September 8, 2017
A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasisOmid Roostaeyan, Dario Kivelevitch, Alan Menter
Immunotherapy|October 17, 2017
CAR-T cells and allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemiaJun Liu, Xi Zhang, Jiang F Zhong, et al.
Immunotherapy|October 17, 2017
Coccidioidomycosis, immunoglobulin deficiency: safety challenges with CAR T cells therapy for relapsed lymphomaUmar Zahid, Al-Aman Shaukat, Nida Hassan, et al.
Immunotherapy|October 17, 2017
Melanoma: a prototype of cancer-testis antigen-expressing malignanciesSepideh Faramarzi, Soudeh Ghafouri-Fard
Immunotherapy|July 9, 2016
A novel microcrystalline tyrosine-adsorbed, mite-allergoid subcutaneous immunotherapy: 1-year follow-up reportAlbert Roger, Nathalie Depreux, Yanina Jurgens, et al.
Immunotherapy|August 4, 2017
Overcoming barriers of car T-cell therapy in patients with mesothelin-expressing cancersMark H O'Hara, Caitlin Stashwick, Gabriela Plesa, et al.
Immunotherapy|June 29, 2016
Targeting KIT on innate immune cells to enhance the antitumor activity of checkpoint inhibitorsMaximilian Stahl, Richard Gedrich, Ronald Peck, et al.
Immunotherapy|May 4, 2016
In vitro Treg expansion favors the full-length splicing isoform of CTLA4Tanja Kaartinen, Heidi Harjunpää, Jukka Partanen, et al.
Immunotherapy|May 4, 2016
Effect of passive immunotherapy against Clostridium difficile infection: a systematic review and meta-analysisThirumalai Diraviyam, Jin-Xin He, Chen Chen, et al.
Pageof 190